The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels (Q37994720)
Jump to navigation
Jump to search
scientific article published on 16 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels |
scientific article published on 16 March 2012 |
Statements
1 reference
The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels (English)
1 reference
Neil Brickel
1 reference
Paul Gandhi
1 reference
Kevan VanLandingham
1 reference
Janet Hammond
1 reference
Sarah DeRossett
1 reference
16 March 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference